This HTML5 document contains 124 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.15283/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37344037
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel wissenschaftlicher Artikel artículu científicu espublizáu en 2013 vetenskaplig artikel artigo científico научни чланак vědecký článek наукова стаття, опублікована в травні 2013 مقالة علمية نشرت في مايو 2013 articolo scientifico vedecký článok article científic bilimsel makale videnskabelig artikel article scientifique scientific article published on May 2013
p:P577
wds:Q37344037-7232D770-7F59-44B8-AD9B-9525BA5207D8
wdt:P577
2013-05-01T00:00:00Z
p:P407
wds:Q37344037-7011D109-B1B7-4865-A975-32074263385B
wdt:P407
wd:Q1860
p:P2860
wds:Q37344037-2E056D14-31F3-4BDD-BA30-2B6F75CA7981 wds:Q37344037-4BE4C5AF-3C85-4125-9357-B2CC34194362 wds:Q37344037-4C47E0D5-63DF-4E8B-ADE7-1C7E378B382C wds:Q37344037-4FD17E95-CCB8-47CD-8EB4-5BB60D12D125 wds:Q37344037-540AE022-D066-4FDA-B1D5-8107BB20CB3B wds:Q37344037-5415001A-7CC7-4947-929D-E61C191FA71D wds:Q37344037-577C7A5A-46A3-4C28-9516-E44AF4EB086B wds:Q37344037-E6EC5218-6E94-4789-A6C0-C5396C07CEA8 wds:Q37344037-E8614BEE-EFEF-4378-B124-0C6A66566E8A wds:Q37344037-F1EAA08E-D86D-49B6-A0ED-08D627D9EFB0 wds:Q37344037-F26D60DA-4AED-4E3E-8F43-6F6FD90858C3 wds:Q37344037-F2E88824-0A12-45CE-977E-843A46A268C2 wds:Q37344037-FEDAD32F-06A6-4C26-AB11-72C9B3494BF3 wds:Q37344037-04ABF8D3-6CD3-4FD5-9847-525300E7B11E wds:Q37344037-056EFE69-C8D5-40A5-AA22-5458B1A1E320 wds:Q37344037-1B547ACC-D88B-4CEC-AE79-DEE4481211AF wds:Q37344037-7E352A78-1987-492E-8718-9812D5681A7C wds:Q37344037-8782FEAD-BE54-43E9-97AD-E3F8D6C5D2DC wds:Q37344037-9227B586-BF80-4F37-8882-8A6823C4F35F wds:Q37344037-9B343A5D-6881-41CE-A786-E1088FD810BF wds:Q37344037-9CCD9F00-6224-4270-AF95-605C5A75D04B wds:Q37344037-A03428EF-F434-4C35-B5E9-C7ED57160B95 wds:Q37344037-A57CA971-53B7-4FF8-B1E1-B4635B5B6BAB wds:Q37344037-AF1779D7-FA1B-4941-B1DF-95F681F03B32 wds:Q37344037-B9DD943E-01E4-4458-B281-1C32730B2CEF wds:Q37344037-BEE796DD-5554-4068-9A2E-AA22D3126E22 wds:Q37344037-D25E667D-5EB5-4E60-9E7A-7F72D114767E wds:Q37344037-244F23EE-FABA-481E-8A87-DA0CC18CF9FD
wdt:P2860
wd:Q82037810 wd:Q84566396 wd:Q42158202 wd:Q45870449 wd:Q56287926 wd:Q33918391 wd:Q73305416 wd:Q39701367 wd:Q39349848 wd:Q35007558 wd:Q74139377 wd:Q33389973 wd:Q55052558 wd:Q40018689 wd:Q37495106 wd:Q39607133 wd:Q37968756 wd:Q43619839 wd:Q37035997 wd:Q39934803 wd:Q39746690 wd:Q53372197 wd:Q33372068 wd:Q38511339 wd:Q74811727 wd:Q78023076 wd:Q39348816 wd:Q52887385
p:P2093
wds:Q37344037-66754F2D-98D4-4702-80F4-457FF08003BF wds:Q37344037-9D56F6EF-7195-4CA8-B515-F4CC644DFC98 wds:Q37344037-C7A513DA-D4B5-4099-BE98-9B1442F93A4D wds:Q37344037-BA3ED3DC-7748-4493-BACC-827B94F8DBB7 wds:Q37344037-18C8AB3E-BF5F-4C9B-99AF-49C2D45D9413 wds:Q37344037-FFB8FE30-0044-4901-B539-881A2A6D8293
wdt:P2093
Dong-Ik Kim Na-Ri Kim Kwang-Bo Park Kyounghwan Roh Young-Soo Do Shin-Seok Yang
rdfs:label
A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease
skos:prefLabel
A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease
schema:name
A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease
p:P50
wds:Q37344037-B2C549D3-EF28-4CD9-931B-47AA9866EC10
wdt:P50
wd:Q96136565
p:P1476
wds:Q37344037-7CAC915E-5A3F-4035-8A66-1D81252631AB
wdt:P1476
A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease
p:P304
wds:Q37344037-D3FD13FE-C862-470E-B39D-94C6D85B7695
wdt:P304
37-44
p:P31
wds:Q37344037-F9C1B02D-C0B6-40E0-B000-706334FDF25B
wdt:P31
wd:Q13442814
p:P698
wds:Q37344037-FD5A9834-C6EC-4363-BB8C-B451725766A0
wdtn:P698
n12:24298372
wdt:P698
24298372
p:P1433
wds:Q37344037-55882450-3E71-4D66-B51B-16CC46F265BD
wdt:P1433
wd:Q26842430
p:P433
wds:Q37344037-25B6491D-1318-43FC-9E2C-7CC429FBF854
p:P478
wds:Q37344037-9CA9A41B-2342-4D53-A8D0-14016C201BF2
wdt:P433
1
wdt:P478
6
p:P356
wds:Q37344037-FB9F5FB2-7E19-4D6B-A454-7210FA72EDA4
wdtn:P356
n9:IJSC.2013.6.1.37
wdt:P356
10.15283/IJSC.2013.6.1.37
p:P275
wds:Q37344037-349b2182-b1ea-4b28-912e-2c1352b527f8
p:P6216
wds:Q37344037-bcfba443-1886-453d-acdb-9783fc7dce3b
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P932
wds:Q37344037-40DC6435-B728-4B52-AE45-346AAA0023DE
wdt:P932
3841002